OpGen Inc (OPGN) has gained 85.37% in a Week, Should You Buy?

OpGen Inc (OPGN) is around the top of the Diagnostics & Research industry according to InvestorsObserver. OPGN received an overall rating of 63, which means that it scores higher than 63 percent of all stocks. OpGen Inc also achieved a score of 96 in the Diagnostics & Research industry, putting it above 96 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 116 out of the 148 industries.

OPGN has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on OPGN!

See Full OPGN Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 63 would rank higher than 63 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With OpGen Inc Stock Today?

OpGen Inc (OPGN) stock is lower by -17.38% while the S&P 500 has risen 0.5% as of 9:32 AM on Friday, Oct 13. OPGN is lower by -$0.16 from the previous closing price of $0.92 on volume of 1,914,087 shares. Over the past year the S&P 500 is higher by 19.12% while OPGN is lower by -81.19%. OPGN lost -$11.97 per share the over the last 12 months. Click Here to get the full Stock Report for OpGen Inc stock.